| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
49 companies · Health Care
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | DHR Danaher CORP /de/ | List Teri | Director | Sell | 3,298 | $226.50 | $746,997.00 | -13.7% | - | - | |
| Nov 18, 2025 | OPK Opko Health, INC. | Frost Phillip Md Et Al | CEO &Chairman | Buy | 413,227 | $1.27 | $525,119.39 | - | - | - | |
| Nov 18, 2025 | TWST Twist Bioscience CORP | Johannessen Jan | Director | Sell | 7,044 | $24.77 | $174,479.88 | -32.2% | - | - | |
| Nov 18, 2025 | MEDP Medpace Holdings, INC. | Troendle August J. | CEO | Sell | 7,191 | $590.84 | $4,248,730.44 | -0.8% | - | - | |
| Nov 18, 2025 | CSTL Castle Biosciences INC | Maetzold Derek J | Pres. &Chief Exec. Officer | Sell | 2,678 | $34.02 | $91,105.56 | -5.0% | - | - | |
| Nov 18, 2025 | RDNT Radnet, INC. | Patel Mital | EVP Of Fin Planning, CAO | Sell | 34,920 | $77.18 | $2,695,100.00 | -8.0% | - | - | |
| Nov 17, 2025 | GRAL Grail, INC. | Freidin Aaron | Chief Financial Officer | Sell | 1,697 | $79.20 | $134,402.40 | -0.6% | - | - | |
| Nov 17, 2025 | MEDP Medpace Holdings, INC. | Troendle August J. | CEO | Sell | 20,794 | $594.02 | $12,352,076.22 | -1.1% | - | - | |
| Nov 14, 2025 | MEDP Medpace Holdings, INC. | Kraft Robert O. | Director | Sell | 6,472 | $591.85 | $3,830,453.20 | -88.6% | - | - | |
| Nov 13, 2025 | TMO Thermo Fisher Scientific INC. | Lagarde Michel | Executive Vice President &COO | Sell | 4,638 | $594.42 | $2,756,919.96 | -16.5% | -6.4% | - | |
| Nov 13, 2025 | MEDP Medpace Holdings, INC. | Troendle August J. | CEO | Sell | 5,128 | $601.37 | $3,083,825.36 | -0.6% | - | - | |
| Nov 12, 2025 | TMO Thermo Fisher Scientific INC. | Britt Lisa P. | Sr. VP And Chief Hr Officer | Sell | 1,058 | $588.27 | $622,135.53 | -7.5% | -7.7% | - | |
| Nov 12, 2025 | DHR Danaher CORP /de/ | Rales Mitchell P | Chairman Of Exec. Committee | Sell | 413,641 | $218.60 | $90,423,682.70 | -15.5% | -1.3% | - | |
| Nov 12, 2025 | A Agilent Technologies, INC. | McDonnell Padraig | President And CEO | Sell | 12,490 | $150.00 | $1,873,500.00 | -27.2% | - | - | |
| Nov 12, 2025 | DHR Danaher CORP /de/ | Ellis Brian W | Senior Vice President - GC | Sell | 21,776 | $219.23 | $4,773,863.14 | -42.8% | -1.3% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.